Author Bio Born and raised in the Deep South of Georgia, Jason now calls Southern California home. A Fool since 2006, he began contributing to Fool.com in 2012. Trying to invest better? Like learning about companies with great (or really bad) stories? Jason can usually be found there, cutting through the noise and trying to get to the heart of the story. Follow @TMFVelvetHammer Clover Health (NASDAQ:CLOV) has been one of the most controversial Medicare insurance providers since being brought public by Social Capital and Hedosophia. In this episode of Industry Focus: Wildcard, Motley Fool contributor Jason Hall and analyst Emily Flippen discuss Clover's business and its unique value proposition, and then debate whether the controversial short-seller report should have investors running for the door.